Patent · US Active

Ligands for prevention of neurotoxicity of the alzheimer's disease related amyloid-beta peptide

US10023610B2 · kind B2 · utility

0Cited by

1References

8Claims

0Family size

Assignee

AlphaBeta AB · SE

Inventors

Roger Strömberg · Huddinge, SE
Dmytro Honcharenko · Stockholm, SE
Jyotirmoy Maity · Stockholm, SE
Alok Juneja · Stockholm, SE
Firoz Roshan Kurudenkandy · Stockholm, SE
Jenny Presto · Stockholm, SE
Lisa Dolfe · Stockholm, SE
André Fisahn · Stockholm, SE
Jan Johansson · Stockholm, SE
Lennart Nilsson · Stockholm, SE

Key dates

Filing date	Jan 16, 2015
Grant date	Jul 17, 2018
Priority date	—
Expiry date	Jan 18, 2035

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/2821
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the field of molecular biochemistry and medicine, and in particular to ligands comprising modified amino acid residues, targeting the amyloid-β peptide associated with Alzheimer's disease for prevention of aggregation, neurotoxicity and use thereof as drugs for treatment of Alzheimer's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.